Amphastar Pharmaceuticals (AMPH) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

AMPH Amphastar Pharmaceuticals

Watchlist

31.020
-0.720-2.27%

Close Feb 14 16:00 ET

31.000
-0.020-0.06%

Post 20:01 ET

1.49BMarket Cap10.31P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

J.P. Morgan Maintains Amphastar Pharmaceuticals(AMPH.US) With Buy Rating, Cuts Target Price to $45
Moomoo NewsFeb 14 16:31 ET · Ratings
Unpacking Q3 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) In The Context Of Other Generic Pharmaceuticals Stocks
Yahoo FinanceFeb 14 04:01 ET
Express News | Amphastar Pharmaceuticals Inc : JP Morgan Cuts Target Price to $45 From $60
ReutersFeb 14 03:00 ET
Here's Why Amphastar Pharmaceuticals (NASDAQ:AMPH) Has Caught The Eye Of Investors
Simply Wall StFeb 8 08:26 ET
This Ollie's Bargain Outlet Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
BenzingaFeb 4 08:58 ET
Piper Sandler Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Maintains Target Price $36
Moomoo NewsFeb 4 07:31 ET · Ratings

Comments

Analysts Notebook

Sep 5, 2024 06:06

Columns 'Trump Trade' vs. 'Harris Trade': How They Could Shape Your Portfolio

The 2024 U.S. presidential race between former President Donald Trump and current Vice President Kamala Harris is still "incredibly close," according to the latest New York Times survey. As investors await the outcome of the November election, equity analysts are busy parsing through the candidates' pronouncements for clues on which stocks could benefit from their policies.
Jefferies analysts cited 10 possible policies that Tr...

Trump trade: Bitcoin hit record highs and Tesla hits $1 trillion market cap

Meltyy

May 23, 2024 09:18

$Amphastar Pharmaceuticals (AMPH.US)$ 📣 Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol
✨Bioequivalent and therapeutically equivalent to $TEVA ProAir® HFA Inhalation Aerosol
» ANDA approval
» Indication: Tx or prevention of bronchospasm 🫁
» Product launch in Q3 '24

Moomoo AI

Jan 19, 2024 13:36

The market's growth expectations seem moderated as EPS growth outpaces average annual share price increase. The recent rise in total shareholder return could suggest business improvement over time.

Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Performs Better Than Its Underlying Earnings Growth Over Last Three Years

Moomoo AI

Dec 20, 2023 05:52

The impressive EPS growth and large insider ownership make Amphastar Pharmaceuticals a potentially attractive investment. The business appears to have reached a growth inflection point.

If EPS Growth Is Important To You, Amphastar Pharmaceuticals (NASDAQ:AMPH) Presents An Opportunity

Explore moomoo's "Insider Activity" for institutional sentiment

Moomoo AI

Nov 18, 2023 06:41

Insider ownership is moderately high, showing company's interest for all shareholders, but the lack of insider buying and significant selling over the last year, casts some doubt on the company's outlook.